The How I Treat Bladder Cancer in 2026 is a global virtual medical congress dedicated entirely to bladder cancer, focusing on screening, early diagnosis, multidisciplinary treatment strategies, and future directions in prevention and disease control.
Event Details
Date: May 20, 2026
Format: Virtual Summit
Registration: Link to Register
Live Streaming: YouTube | X
The OncoDaily How I Treat series returns with a dedicated global summit on bladder cancer treatment, bringing together leading oncology experts to explore the latest advances in the management of urothelial carcinoma in 2026.
Taking place on May 20, during Bladder Cancer Awareness Month, the summit brings together leading experts from across continents to discuss current standards of care, emerging therapies, precision medicine approaches, and evolving clinical practices shaping the future of bladder cancer management.
Bladder cancer accounts for an estimated 614,000 new cases and 220,000 deaths worldwide each year, according to the International Agency for Research on Cancer’s GLOBOCAN data. Outcomes vary markedly by stage: 5-year relative survival is about 98% for in situ disease, 73% for localized disease, 41% for regional disease, and only 9% for distant metastatic disease. Although many patients are diagnosed with non-muscle-invasive tumors, muscle-invasive and metastatic bladder cancer continue to carry a substantial risk of recurrence and cancer-related death. Simultaneously, the incorporation of immunotherapy, antibody-drug conjugates, and biomarker-guided approaches is transforming how advanced urothelial carcinoma is treated, leading to better long-term results for some patients.
Scientific Program Overview
How I Treat Bladder Cancer Summit will explore the full clinical spectrum of bladder cancer, emphasizing practical, experience-based management in 2026. The program will address contemporary approaches to suspected and newly diagnosed disease through risk-adapted decision-making, as well as evidence-based strategies for non-muscle-invasive, muscle-invasive, and advanced or metastatic bladder cancer. Sessions will examine structured treatment principles that guide daily clinical practice, including the selection of systemic and local therapies, the sequencing of novel agents such as immunotherapy and targeted treatments, multidisciplinary coordination, and individualized patient care.
The OncoDaily Bladder Cancer Summit 2026 brings together top specialists to translate these emerging findings into actionable, real-world treatment plans. The focus is on boosting survival rates, refining multidisciplinary care, and addressing disparities in patient outcomes worldwide.